Novel antifungal agent, exhibiting broad spectrum and potent activity against 12 kinds of clinically pathogenic fungi

Novel Potent Fungal-Selective Inhibitor of Mitochondrial Cytochrome bc1

Natural Activator of Programmed Cell Death, leading to membrane damage, mitochondria alteration, chromatin condensation, and ROS accumulation

Inhibitor of both topoisomerase I and II via intercalating DNA helix

Natural potent inhibitor of H. pylori DHODH, having greater efficacy for treatment of H. pylori infection

Blocker of the interaction of FAK and IGF-1R; Antagonist of the phosphorylation of tumor AKT

Activator of the P2Y6 receptor in bone, increasing survival of osteoclasts

Novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo

Novel potent inhibitor of DDR1 tyrosine kinase

Novel putative inhibitor of type III secretion (T3S) in the Gram-negative pathogen Yersinia pseudotuberculosis and Chlamydia trachomatis

Novel Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model

Novel Potent and Selective Inducible Nitric Oxide Synthase (iNOS) Inhibitor (IC50 = 74 nM) with high BBB permeability (Pe = 19.1 × 10-6 cm/s) for Parkinson's Disease

Novel selective inhibitor of the iNOS, without affecting the eNOS isoform

Novel Potent Inhibitor of Microbiome ß-Glucuronidases

Novel Potent Inhibitor of Microbiome ß-Glucuronidases

Novel dual inhibitor of MAPKAPK5 and MAPKAPK2

Novel inhibitor of Ark1, the fission yeast member of the conserved Aurora kinase family

Novel inhibitor of the influenza virus reproduction, inhubiting the formation of the virus specific hemagglutinin

NIR emitting firefly luciferin analogue

Metabolite of tryptophan, showing adverse effects on bones and the central nervous system, having been most frequently implicated as a contributor to renal disease progression and vascular disease

Novel sPLA2 inhibitor, suppressing murine endotoxic shock and LDL modification, blocking binding to the M-type receptor

Topoisomerase I (Top1) inhibitor

Novel inhibitor of dihydroorotate dehydrogenase (DHODH), promoting myeloid differentiation and inhibiting the proliferation of acute promyelocytic leukemia HL-60 cells, also suppressing cell growth in various other types of cancer cells

Natural antibiotic, selectively inhibiting bacterial tryptophanyl-tRNA synthetase (TrpRS)

Metabolite of tryptophan, reducing the interleukin-8 (IL-8) response after IL-1β stimulus, interacting with the transcription factor aryl hydrocarbon receptor (AHR) and preventing transcription of the inflammatory cytokine IL-8, being anti-inflammatory in

Platelet aggregation inhibitor acting as a reversible Cyclooxygenase>cyclooxygenase inhibitor

Topoisomerase I (Top1) inhibitor

Antidepressant and cerebral activator, acting as a serotonin releasing agent, norepinephrine reuptake inhibitor, and NMDA receptor antagonist, enhancing acetylcholine release via activation of the 5-HT4 receptor

Selective estrogen receptor modifier (SERM), being a selective ERß agonist

Antiprion agent, reducing PrP(Sc) levels in dividing and stationary-phase cells